$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

통풍환자에 대한 간호사 주도 환자교육의 효과
Effects of Nurse-led Patient Education for Gout Patients 원문보기

산업융합연구 = Journal of industrial convergence, v.20 no.7, 2022년, pp.97 - 105  

유인설 (세종충남대학교병원 류마티스내과) ,  정선경 (세종충남대학교병원 미래의학연구원)

초록
AI-Helper 아이콘AI-Helper

통풍은 관절염뿐만 아니라 심혈관질환 등을 유발하는 만성염증질환이다. 하지만 대부분의 환자들이 단순히 관절질환으로 인식하고 있어 치료에 장애로 작용한다. 이 연구를 통해 간호사 주도의 통풍환자 대상 교육이 환자의 통풍에 대한 인식 개선 및 질병 경과에 미치는 영향을 확인하고자 하였다. 교육전문 간호사가 상급종합병원 류마티스내과 외래에 내원한 환자를 대상으로 통풍에 대한 일대일 교육을 시행하였고 환자의 만족도 및 복약순응도, 혈중 요산치의 변화 정도를 측정하였다. 교육을 받은 환자군의 진료만족도는 대조군에 비해 유의하게 높았으며 두 번째와 세 번째 외래 방문 시에 측정한 복약순응도와 혈중 요산치는 대조군에 비해 교육군에서 유의하게 개선이 되었다. 결론적으로 간호사 주도 환자교육은 진료 만족도 개선 및 질환 경과의 호전에도 도움이 되는 것으로 확인되었다.

Abstract AI-Helper 아이콘AI-Helper

Objectives: This study was performed to analyze the effect of nurse-led education on results for patients with gout. Methods: The face-to-face education was conducted by a specialist nurse. Patient satisfaction and drug adherence, serum uric acid was assessed. Results: Patient satisfaction was signi...

주제어

참고문헌 (37)

  1. P. Richette et al. (2014). Improving cardiovascular and renal outcomes in gout: what should we target?. Nature reviews. Rheumatology, 10(11), 654-661. DOI : 10.1038/nrrheum.2014.124 

  2. D. I. Feig, D. H. Kang & R. J. Johnson. (2008). Uric acid and cardiovascular risk. The New England journal of medicine, 359(17), 1811-1821. DOI : 10.1056/NEJMra0800885 

  3. R. D. Abbott, F. N. Brand, W. B. Kannel & W. P. Castelli. (1988). Gout and coronary heart disease: the Framingham Study. Journal of clinical epidemiology, 41(3), 237-242. DOI : 10.1016/0895-4356(88)90127-8 

  4. E. Krishnan, J. F. Baker, D. E. Furst & H. R. Schumacher. (2006). Gout and the risk of acute myocardial infarction. Arthritis and rheumatism, 54(8), 2688-2696. DOI : 10.1002/art.22014 

  5. H. K. Choi & G. Curhan. (2007). Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 116(8), 894-900. DOI : 10.1161/CIRCULATIONAHA.107.703389 

  6. M. A. De Vera, M. M. Rahman, V. Bhole, J. A. Kopec & H. K. Choi. (2010). Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Annals of the rheumatic diseases, 69(6), 1162-1164. DOI : 10.1136/ard.2009.122770 

  7. J. F. Baker, H. R. Schumacher & E. Krishnan. (2007). Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology, 58(4), 450-457. DOI : 10.1177/0003319707303444 

  8. E. Krishnan (2012). Gout and the risk for incident heart failure and systolic dysfunction. BMJ open, 2(1), e000282. DOI : 10.1136/bmjopen-2011-000282 

  9. O. O. Seminog & M. J. Goldacre. (2013). Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology(Oxford,England), 52(12), 2251-2259. DOI : 10.1093/rheumatology/ket293 

  10. K. Lottmann, X. Chen & P. K. Schadlich. (2012). Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Current rheumatology reports, 14(2), 195-203. DOI : 10.1007/s11926-011-0234-2 

  11. G. G. Teng, L. W. Ang, K. G. Saag, M. C. Yu, J. M. Yuan & W. P. Koh. (2012). Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study. Annals of the rheumatic diseases, 71(6), 924-928. DOI : 10.1136/ard.2011.200523 

  12. F. Perez-Ruiz, L. Martinez-Indart, L. Carmona, A. M. Herrero-Beites, J. I. Pijoan & E. Krishnan. (2014). Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Annals of the rheumatic diseases, 73(1), 177-182. DOI : 10.1136/annrheumdis-2012-202421 

  13. L. Grimaldi-Bensouda et al. (2015). Impact of allopurinol on risk of myocardial infarction. Annals of the rheumatic diseases, 74(5), 836-842. DOI : 10.1136/annrheumdis-2012-202972 

  14. J. H. Chen et al. (2015). Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study. The Journal of rheumatology, 42(9), 1694-1701. DOI : 10.3899/jrheum.141542 

  15. F. Perez-Ruiz & G. Desideri. (2018). Improving adherence to gout therapy: an expert review. Therapeutics and clinical risk management, 14, 793-802. DOI : 10.2147/TCRM.S162956 

  16. C. F. Kuo, M. J. Grainge, C. Mallen, W. Zhang & M. Doherty. (2015). Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Annals of the rheumatic diseases, 74(4), 661-667. DOI : 10.1136/annrheumdis-2013-204463 

  17. B. McGowan, K. Bennett, C. Silke & B. Whelan. (2016). Adherence and persistence to urate-lowering therapies in the Irish setting. Clinical rheumatology, 35(3), 715-721. DOI : 10.1007/s10067-014-2823-8 

  18. G. Zandman-Goddard, H. Amital, N. Shamrayevsky, R. Raz, V. Shalev & G. Chodick. (2013). Rates of adherence and persistence with allopurinol therapy among gout patients in Israel. Rheumatology (Oxford,England), 52(6), 1126-1131. DOI : 10.1093/rheumatology/kes431 

  19. S. Mantarro, et al. (2015). Allopurinol adherence among patients with gout: an Italian general practice database study. International journal of clinical practice, 69(7), 757-765. DOI : 10.1111/ijcp.12604 

  20. M. Dehlin, E. H. Ekstrom, M. Petzold, U. Stromberg, G. Telg & L. T. Jacobsson. (2017). Factors associated with initiation and persistence of urate-lowering therapy. Arthritis research & therapy, 19(1), 6. DOI : 10.1186/s13075-016-1211-y 

  21. P. Richette et al. (2017). 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the rheumatic diseases, 76(1), 29-42. DOI : 10.1136/annrheumdis-2016-209707 

  22. P. Richette, R. N. Flipo & D. K. Patrikos. (2015). Characteristics and management of gout patients in Europe: data from a large cohort of patients. European review for medical and pharmacological sciences, 19(4), 630-639. 

  23. M. Hui et al. (2017). The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford,England), 56(7), 1056- 1059. DOI : 10.1093/rheumatology/kex150 

  24. M. Doherty et al. (2018). Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet (London,England), 392(10156), 1403-1412. DOI : 10.1016/S0140-6736(18)32158-5 

  25. C. H. Lee, H. S. Lim, Y. N. Kim, A. H. Park, E. C. Park & J. G. Kang (2014) Analysis of appropriate outpatient consultation time for clinical departments. Health Policy Management 24, 254-260. 

  26. J. Hill. (1997). Patient satisfaction in a nurse-led rheumatology clinic. Journal of advanced nursing, 25(2), 347-354. DOI : 10.1046/j.1365-2648.1997.1997025347.x 

  27. S. K. Cho et al. (2016). Impact of Patient Education on the Satisfaction of Rheumatoid Arthritis Patients: A Randomized Trial of Nurse-led Versus Medical Docter-led Education. Journal of Rheumatic Diseases 23, 109-117. DOI : 10.4078/jrd.2016.23.2.109 

  28. Y. I. Seo et al. (2011). Survey of Current Trends for Diagnosis and Treatment in Korean Gout Patients. Journal of Rheumatic Diseases. 18(3), 187-192. DOI : 10.4078/jrd.2011.18.3.187 

  29. M. Doherty et al. (2012). Gout: why is this curable disease so seldom cured?. Annals of the rheumatic diseases, 71(11), 1765-1770. DOI : 10.1136/annrheumdis-2012-201687 

  30. K. Spencer, A. Carr& M.Doherty. (2012). Patient and provider barriers to effective management of gout in general practice: a qualitative study. Annals of the rheumatic diseases, 71(9), 1490-1495. DOI : 10.1136/annrheumdis-2011-200801 

  31. H. A. Zangi et al. (2015). EULAR recommendations for patient education for people with inflammatory arthritis. Annals of the rheumatic diseases, 74(6), 954-962. DOI : 10.1136/annrheumdis-2014-206807 

  32. H. S. Koksvik, K. B. Hagen, E. Rodevand, P. Mowinckel, T. K. Kvien & H. A. Zangi. (2013). Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides. Annals of the rheumatic diseases, 72(6), 836-843. DOI : 10.1136/annrheumdis-2012-202296 

  33. S. Ryan, A. Hassell, C. Thwaites, K. Manley & D. Home. (2007). Developing a new model of care for patients with chronic musculoskeletal pain. Journal of nursing management, 15(8), 825-829. DOI : 10.1111/j.1365-2934.2007.00761.x 

  34. P. Makelainen, K. Vehvilainen-Julkunen & A. M. Pietila (2009). Rheumatoid arthritis patient education: RA patients' experience. Journal of clinical nursing, 18(14), 2058-2065. DOI : 10.1111/j.1365-2702.2008.02763.x 

  35. C. E. Golin et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of general internal medicine, 17(10), 756-765. DOI : 10.1046/j.1525-1497.2002.11214.x 

  36. Y. van Eijk-Hustings et al. (2012). EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Annals of the rheumatic diseases, 71(1), 13-19. DOI : 10.1136/annrheumdis-2011-200185 

  37. N. Valentine, C. Darby & G. J. Bonsel (2008). Which aspects of non-clinical quality of care are most important? Results from WHO's general population surveys of "health systems responsiveness" in 41 countries. Socia lscience & medicine(1982), 66(9), 1939-1950. DOI : 10.1016/j.socscimed.2007.12.002 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로